WHAT ARE THE PRESCRIPTION LIMITS FOR DANGEROUS DRUGS’ PREPARATIONS?  

 

The following are the prescription limits of dangerous drugs’ preparations that may be prescribed in a single applicable prescription by a licensed practitioner:

A. FOR CANCER PATIENTS:
1. Morphine Sulfate (tablets) 3,000 mg
MorphineSulfate (ampoules/vials) 448 mg
2. Fentanyl patch 25 ug/hour 30 patches
Fentanyl patch 50 ug/hour 15 patches
Fentanyl ampoules 50 ug/mL
  • 10 ampoules (1mL)
  • 3 ampoules (2mL)
  • 50 ampoules (2mL)for use in Patient
  • Controlled Analgesic
  • (PCA) machine
  • 10 ampoules (10mL)for use in Patient Controlled Analgesic (PCA) machine
3. Oxycontin 1,200 mg

Oxycontin 10 mg

120 tablets
Oxycontin 20 mg 60 tablets
Oxycontin 40 mg 30 tablets
Oxycontin 80 mg 15 tablets
4. Demerol 14 vials
5. Dangerous Drugs (ampoules or 20 pieces
hypodermic tablets 40 pieces
Dangerous Drugs (tablets) 40 pieces
B. FOR ORDINARY CIRCUMSTANCES
1. Benzodiazepines (anxiolytic or hypnotic or both) 30 tabs or caps
Benzodiazepines (anxiolytic or hypnotic or both)
  • 30 tabs or caps
  • 10 ampoules x 1 mL
  • 3 ampoules x 2 mL
  • 2 ampoules x 3 mL
  • 2 ampoules x 5 mL
  • 1 ampoule x 10 mL
Benzodiazepine (muscle spasm/dystonia/tetanus) 90 tablets (5 mg)
2. Phenobarbital preparations
  • 2 weeks supply
  • 2 bottles (100 tablet each) for Epileptic patients
3. Sodium Pentothal 3 vials (in case of hospital use)
4. Demerol 3 Ampoules
5. Other Dangerous Drugs (in vials) 1 vial (in case of hospital use)
6. Ephedrine (parenteral form) 1 vial
Ephedrine, pseudoephedrine, norepher drine (tablet/capsule) 1.6 grams of base

 

 

Back to Top

 

WHAT ARE THE INFORMATION CONTAINED IN A DANGEROUS DRUG PREPARATION’S PRESCRIPTION?

 

The following are the information contained in a dangerous drug preparation’s prescription:

DATE OF PRESCRIPTION;

1. COMPLETE NAME & ADDRESS OF PATIENT;

2. COMPLETE NAME , ADDRESS, & TELEPHONE NUMBER OF PRESCRIBING PRACTITIONER;

3. PRESCRIBING PRACTITIONER’S CURRENT S-2 LICENSE NO., PRC REGISTRATION NO., & PTR NO., & SIGNATURE;

4. BRAND NAME & GENERIC NAME, TOTAL NO. OF UNITS TO BE SUPPLIED IN WORDS FOLLOWED BY ITS ROMAN NUMERAL ENCLOSED IN PARENTHESIS;

5. DIRECTION FOR USE & THE WORDS ‘NON-REPETITION.”

 

next previous